February 9, 2011 -- Fosun Pharmaceutical has bought a 75% stake in Dalian Aleph Biomedical, a vaccine maker, at a price reported as 675 million RMB ($102.4 million). Established in 2002, Aleph’s main product is an inactivated split flu vaccine. More details....
